G-CSF
DrugG-CSF & Antibiotic therapy in combination
NCT Number: NCT06988826
This study aim to find the best option for children having cancer who develop low immunity state due to chemotherapy
Trial opening soon.
Get Notified1 year–16 year
All sexes
Interventional
Phase 4
Children having a cancer diagnosis and treated with chemotherapy often develop neutropenia. This creates an immunocompromised state which can result in infections manifested by fever. This study compares two treatment options to find out the best treatment for these patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
G-CSF & Antibiotic therapy in combination
Antibiotics alone
Time frame: 2 weeks
Duration of resolution of febrile neutropenia (in days)
Time frame: 2 weeks
Duration of resolution of fever (in days)
Time frame: 2 weeks
Length of hospital stay (in days)
King Edward Medical University
Other
Comparison of Antibiotics With and Without Granulocyte Colony-Stimulating Factor in Children With Chemotherapy Induced Febrile Neutropenia
Acronym: AGF-FN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06500715
Agranulocytosis, Cross Infection
Jerusalem, Israel
View Trial DetailsNCT06697262
Agranulocytosis, Cytopenia
View Trial DetailsNCT06450821
Agranulocytosis, Cytopenia
Leeds, West Yorkshire, United Kingdom
View Trial DetailsNCT06278896
Agranulocytosis, Antibiotic Stewardship
View Trial Details